Risdiplam Completed Phase 2 Trials for Spinal Muscular Atrophy (SMA) Treatment

Indications	Status	Purpose	Phase
DBCOND0058632 (Spinal Muscular Atrophy (SMA))	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT02908685	A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants	Risdiplam (DB15305)
NCT02913482	Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy	Risdiplam (DB15305)